SCHEMBL5015032

SCHEMBL5015032

[CH2]CCOCCCc1cccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
MCL1 Q07820 1/20 0.42
CYP2C9 P11712 1/20 0.42
SIGMAR1 Q99720 4/20 0.41
SLC18A2 Q05940 1/20 0.40
MTNR1A P48039 1/20 0.40
NQO2 P16083 1/20 0.40
CYP2D6 P10635 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3113301 0.90 CYP1A2 (0.44) CYP1A2CYP2C19CYP2C9MTNR1ANQO2
SCHEMBL2092694 0.89 SIGMAR1 (0.42) GPR84CYP1A2CYP2C19CYP2C9SIGMAR1
SCHEMBL108121 0.82 CYP1A2 (0.50) GPR84CYP1A2CYP2C19MCL1CYP2C9
SCHEMBL27873879 0.82 CNR2 (0.45) GPR84CYP1A2CYP2C19MCL1CYP2C9
SCHEMBL12251120 0.81 BCHE (0.45) GPR84CYP1A2CYP2C19CYP2C9SIGMAR1
SCHEMBL2094192 0.81 NQO2 (0.46) GPR84CYP1A2CYP2C19MCL1CYP2C9
SCHEMBL6420346 0.81 CYP1A2 (0.46) CYP1A2CYP2C19CYP2C9CYP2D6
SCHEMBL134471 0.80 CYP1A2 (0.48) GPR84CYP1A2CYP2C19MCL1CYP2C9
SCHEMBL586305 0.80 CYP1A2 (0.52) CYP1A2CYP2C19CYP2C9SLC18A2MTNR1A
Hydrochloric Acid SCHEMBL9517776 0.80 BCHE (0.47) CYP1A2CYP2C19CYP2C9SIGMAR1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed